MS Contin
These highlights do not include all the information needed to use MS CONTIN safely and effectively. See full prescribing information for MS CONTIN. MS CONTIN (morphine sulfate extended-release tablets), for oral use CII Initial U.S. Approval: 1941
c354b3bf-86c0-4bb8-8b1f-be2164942698
HUMAN PRESCRIPTION DRUG LABEL
Dec 27, 2023
Rhodes Pharmaceuticals L.P.
DUNS: 831928986
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
morphine sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
morphine sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
morphine sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
morphine sulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
morphine sulfate
Product Details
FDA regulatory identification and product classification information